These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 22673409

  • 1. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome.
    Woo HY, Kim KH, Rhee EJ, Park H, Lee MK.
    Endocr J; 2012; 59(9):781-90. PubMed ID: 22673409
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 4. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Aug; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S, Ruan J, Huang W, Tan J, Zhang X, Feng X, Liu D, Fu J, Zhou L, Zhou M.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
    Song DK, Oh JY, Lee H, Sung YA.
    Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
    [Abstract] [Full Text] [Related]

  • 9. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P, Cygal A, Madej P, Dąbkowska-Huć A, Sikora J, Martirosian G, Romanik M, Olszanecka-Glinianowicz M.
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [Abstract] [Full Text] [Related]

  • 10. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T, Munkhzaya M, Iwasa T, Tungalagsuvd A, Yano K, Mayila Y, Yanagihara R, Tokui T, Kato T, Kuwahara A, Matsui S, Irahara M.
    Endocr J; 2017 May 30; 64(5):531-541. PubMed ID: 28381699
    [Abstract] [Full Text] [Related]

  • 11. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y, Shi Y, Cui L, Han T, Gao X, Chen ZJ.
    Fertil Steril; 2014 Jul 30; 102(1):230-236.e2. PubMed ID: 24746743
    [Abstract] [Full Text] [Related]

  • 12. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
    Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN.
    Hum Reprod; 2008 Apr 30; 23(4):952-7. PubMed ID: 18256110
    [Abstract] [Full Text] [Related]

  • 13. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A, Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Milewski R, Górska M, Wołczyński S, Kowalska I.
    Metabolism; 2016 May 30; 65(5):804-811. PubMed ID: 26961579
    [Abstract] [Full Text] [Related]

  • 14. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 May 30; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 15. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M, Sahin Ersoy G, Yayla Abide C, Sanverdi İ, Devranoglu B, Kutlu T, Çevik Ö.
    J Obstet Gynaecol; 2019 Oct 30; 39(7):975-980. PubMed ID: 31064233
    [Abstract] [Full Text] [Related]

  • 16. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D.
    Am J Physiol Endocrinol Metab; 2009 Feb 30; 296(2):E238-43. PubMed ID: 18957615
    [Abstract] [Full Text] [Related]

  • 17. Anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome.
    Sathyapalan T, Al-Qaissi A, Kilpatrick ES, Dargham SR, Atkin SL.
    Clin Endocrinol (Oxf); 2018 Feb 30; 88(2):258-262. PubMed ID: 29144548
    [Abstract] [Full Text] [Related]

  • 18. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX, Li Y, Hu R, Wang FM, Zhang XM, Guan B.
    J Assist Reprod Genet; 2016 Feb 30; 33(2):199-205. PubMed ID: 26732661
    [Abstract] [Full Text] [Related]

  • 19. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F, Liu XL, Rong N, Huang XW.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb 30; 37(1):70-73. PubMed ID: 28224431
    [Abstract] [Full Text] [Related]

  • 20. Advantages of Serum Anti-Müllerian Hormone as a Marker for Polycystic Ovarian Syndrome.
    Shi X, Peng D, Liu Y, Miao X, Ye H, Zhang J.
    Lab Med; 2019 Jul 16; 50(3):236-242. PubMed ID: 30535164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.